Zosano Pharma Corporation announced a manufacturing and supply agreement for M207 with a leading global contract development and manufacturing organization, which serves more than 400 clients in the pharmaceutical and biotechnology sectors. Under the terms of the agreement, Zosano will transfer its proprietary technology for the coating of zolmitriptan onto the ADAM delivery system. Additionally Zosano has entered into a long-term manufacturing and supply agreement. “This agreement...